10 Jan 2023 ExeVir Bio secures EUR 25 million venture debt financing from the European Investment Bank Member news
09 Jan 2023 Foundational RNA and cLNP expert Antonin (Tony) de Fougerolles joins eTheRNA as independent board member Member news
06 Jan 2023 UCB announces rozanolixizumab BLA for the treatment of generalized myasthenia gravis filed with U.S. FDA and designated for Priority Review Member news
20 Dec 2022 Richter and Mithra sign binding Heads of Terms for commercialization of Donesta® Member news
19 Dec 2022 FINTEPLA®▼ (fenfluramine) oral solution recommended for approval in the EU for adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS) Member news
19 Dec 2022 FOx BIOSYSTEMS receives € 2.5 million EIC grant to accelerate the market introduction of unique EV analysis and isolation application Member news
16 Dec 2022 Oxurion announces the continuation of KALAHARI Phase 2, Part B Study in diabetic macular edema following interim analysis Member news
16 Dec 2022 Beiersdorf acquires S-Biomedic and strengthens expertise in the field of acne treatment Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
